Summary of Key Information:
Reporting Period (Quarter/Year): Quarter ended June 30, 2026 (Q1 FY27)
Nature of Filing / Announcement: Outcome of Board Meeting under SEBI LODR Regulations 30 and 33
Audit Opinion:
Clean, Unqualified Review Report. The statutory auditors, MSKA & Associates LLP, stated: "nothing has come to our attention that causes us to believe that the accompanying Statement... contains any material misstatement."
Auditor’s Comment:
Not Specified
Key Financial Highlights [₹ in millions]
Standalone Results:
Revenue from Operations: ₹3,841.01 (vs. ₹2,337.79 in Q4 FY26 and ₹3,673.83 in Q1 FY25)
Total Income: ₹3,852.60
Net Profit: ₹380.52 (vs. ₹39.94 in Q4 FY26 and ₹325.92 in Q1 FY25)
EPS: ₹11.26 (Basic and Diluted)
Other Equity: Not specified for quarter end
Consolidated Results:
Revenue from Operations: Not separately stated (Total Income: ₹3,835.07)
Total Income: ₹3,835.07 (vs. ₹2,381.50 in Q4 FY26 and ₹3,681.55 in Q1 FY25)
Net Profit: ₹381.10 (vs. ₹39.68 in Q4 FY26 and ₹325.87 in Q1 FY25)
EPS: ₹11.28 (Basic and Diluted)
Other Equity: Not specified for quarter end
Segment-wise Performance:
The Group's activities comprise a single business segment: "Agri-Inputs" (manufacturing and dealing in pesticides, insecticides, herbicides, fertilizers, and allied products).
Corporate Actions:
Not Specified
Other Significant Information:
- The company is planning to obtain necessary approvals for incorporating a new Wholly-Owned Subsidiary in Brazil (Foreign Subsidiary).
- The company's business is seasonal in nature, and results can be impacted by weather conditions and cropping patterns.
- The Employee Stock Option Plan 2023 (300,000 share options) was approved, but no options were granted to eligible employees as of June 30, 2026.